James E. Dentzer - 27 Jan 2022 Form 4 Insider Report for CURIS INC (CRIS)

Reporting relationship: President & CEO, Director
Issuer ticker: CRIS
Reported as of: 27 Jan 2022
Net transaction value: -$17,150
SEC form: 4
Accepted by SEC: 31 Jan 2022, 16:14:51 UTC
Next SEC filing: 03 Oct 2022
Source filing: View source filing
Reporting owner signature: William Steinkrauss, attorney-in-fact

Key filing fact

James E. Dentzer filed Form 4 for CURIS INC (CRIS) on 31 Jan 2022.

Key facts

This page summarizes James E. Dentzer's Form 4 filing for CURIS INC (CRIS).
3 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 31 Jan 2022, 16:14.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: -$17,150.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CRIS transaction

Common Stock

Sale

Transaction value: $7,651
Shares: -2,406
Change %: -3.4%
Price: $3.18
Shares after: 67,971
Date: 27 Jan 2022
Ownership: Direct
Footnotes: F1

CRIS transaction

Common Stock

Sale

Transaction value: $9,499
Shares: -3,094
Change %: -4.6%
Price: $3.07
Shares after: 64,877
Date: 31 Jan 2022
Ownership: Direct
Footnotes: F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CRIS transaction Derivative

Employee stock option (right to buy)

Award

Transaction value: $0
Shares: +825,000
Change %
Price: $0.000000
Shares after: 825,000
Date: 29 Jan 2022
Ownership: Direct
Underlying class: Common stock
Underlying amount: 825,000
Exercise price: $3.09
Footnotes: F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Shares were sold pursuant to a "sell to cover" arrangement to satisfy minimum statutory tax withholding obligations related to a vesting of a service-based restricted stock award granted on January 22, 2018.

Footnote F2

This transaction was effected pursuant to Rule 10b5-1 trading plans to cover tax obligations.

Footnote F3

The option grant described in this Form 4 filing vests as to 25% of the original shares on January 29, 2023 and as to an additional 6.25% of the original shares each successive quarter and until January 29, 2026.